Jazz Pharmaceuticals (JAZZ) Current Deferred Tax Assets (2012 - 2015)

Jazz Pharmaceuticals has reported Current Deferred Tax Assets for 4 years, with the latest figure at $50.0 million in Q3 2015.

• For the quarter ending Q3 2015, Current Deferred Tax Assets rose 40.09% year-over-year to $50.0 million; the trailing twelve-month figure through Sep 2015 stood at $50.0 million (up 40.09% YoY), and the FY2014 full-year result was $48.4 million, up 44.11% from the prior year.
• Current Deferred Tax Assets for Q3 2015 stood at $50.0 million, down from $50.6 million in the prior quarter.
• The five-year high for Current Deferred Tax Assets was $50.8 million in Q1 2015, with the low at $33.6 million in Q4 2013.
• Average Current Deferred Tax Assets over 4 years is $43.0 million, with a median of $46.1 million recorded in 2013.
• Peak annual rise in Current Deferred Tax Assets reached 44.11% in 2014, while the deepest fall reached 24.47% in 2014.
• Tracing JAZZ's Current Deferred Tax Assets over 4 years: stood at $35.8 million in 2012, then declined by 6.14% to $33.6 million in 2013, then jumped by 44.11% to $48.4 million in 2014, then increased by 3.23% to $50.0 million in 2015.
• The last three Current Deferred Tax Assets figures came in at $50.0 million (Q3 2015), $50.6 million (Q2 2015), and $50.8 million (Q1 2015), per Business Quant data.

Peer Comparison